| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
189,490,000 |
| Market
Cap: |
1.14(B) |
| Last
Volume: |
2,547,018 |
Avg
Vol: |
4,440,946 |
| 52
Week Range: |
$4.13 - $7.98 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 16.9 |
| Insider 6 Months : 16.9 |
| Insider 3/6 Months : 32.4 |
|
| Guru Rank Number : 455 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO™ (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
183,601 |
183,601 |
183,601 |
183,601 |
| Total Buy Value |
$1,048,338 |
$1,048,338 |
$1,048,338 |
$1,048,338 |
| Total People Bought |
10 |
10 |
10 |
10 |
| Total Buy Transactions |
10 |
10 |
10 |
10 |
| Total Shares Sold |
11,387 |
11,387 |
11,387 |
506,586 |
| Total Sell Value |
$69,059 |
$69,059 |
$69,059 |
$6,068,300 |
| Total People Sold |
2 |
2 |
2 |
10 |
| Total Sell Transactions |
2 |
2 |
2 |
16 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baker Felix |
10% Owner |
– – • |
2008-11-20 |
4 |
B |
$1.00 |
$8,278 |
I/I |
8,278 |
135,639 |
1.5 |
- |
|
| Baker Felix |
10% Owner |
– – • |
2008-11-20 |
4 |
B |
$1.00 |
$2,028 |
I/I |
2,028 |
27,070 |
1.42 |
- |
|
| Stonehouse Jon P |
President & CEO |
• • – |
2008-11-03 |
4 |
B |
$1.74 |
$43,729 |
D/D |
25,000 |
100,603 |
2.81 |
- |
|
| Stonehouse Jon P |
President & CEO |
• • – |
2008-08-12 |
4 |
B |
$3.10 |
$7,124 |
D/D |
2,300 |
75,603 |
2.81 |
- |
|
| Stonehouse Jon P |
President & CEO |
• • – |
2008-08-11 |
4 |
B |
$2.95 |
$22,736 |
D/D |
7,700 |
73,303 |
2.81 |
- |
|
| Grant Stuart |
SR VP & CFO |
• – – |
2008-08-04 |
4 |
B |
$2.82 |
$8,466 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
| Stonehouse Jon P |
President & CEO |
• • – |
2008-08-04 |
4 |
B |
$2.82 |
$677 |
D/D |
240 |
65,603 |
2.73 |
- |
|
| Darwin Michael A |
Principal Accounting Officer |
• – – |
2008-07-31 |
4 |
B |
$2.82 |
$4,823 |
D/D |
1,709 |
3,048 |
2.66 |
- |
|
| Stonehouse Jon P |
President & CEO |
• • – |
2008-01-31 |
4 |
B |
$3.50 |
$10,506 |
D/D |
3,000 |
65,363 |
2.81 |
- |
|
| Darwin Michael A |
Principal Accounting Officer |
• – – |
2008-01-31 |
4 |
B |
$3.50 |
$4,689 |
D/D |
1,339 |
1,339 |
2.66 |
- |
|
| Bennett J Claude |
Chief Operating Officer |
• • – |
2007-09-04 |
4 |
AS |
$12.00 |
$240,000 |
D/D |
(20,000) |
65,730 |
|
- |
|
| Bennett J Claude |
Chief Operating Officer |
• • – |
2007-09-04 |
4 |
OE |
$6.25 |
$127,109 |
D/D |
20,000 |
85,730 |
|
- |
|
| Stonehouse Jon P |
President & CEO |
• • – |
2007-08-14 |
4 |
AB |
$9.86 |
$26,129 |
D/D |
2,650 |
62,363 |
|
- |
|
| Stonehouse Jon P |
President & CEO |
• • – |
2007-08-13 |
4 |
AB |
$9.80 |
$71,863 |
D/D |
7,250 |
59,713 |
|
- |
|
| Baker Felix |
10% Owner |
– – • |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
127,361 |
|
- |
|
| Baker Felix |
10% Owner |
– – • |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,042 |
|
- |
|
| Baker Felix |
10% Owner |
– – • |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,650,290 |
|
- |
|
| Baker Felix |
10% Owner |
– – • |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,006,477 |
|
- |
|
| Baker Felix |
10% Owner |
– – • |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
109,241 |
|
- |
|
| Featheringill William W |
Director |
– • • |
2007-08-06 |
4 |
B |
$7.80 |
$6,485,996 |
I/I |
831,538 |
831,538 |
2.25 |
- |
|
| Stonehouse Jon P |
CEO |
• • – |
2007-07-31 |
4 |
B |
$7.06 |
$17,376 |
D/D |
2,463 |
52,463 |
2.81 |
- |
|
| Nugent Jonathan M |
VP Corp Communications |
• – – |
2007-07-31 |
4 |
B |
$7.06 |
$2,011 |
D/D |
285 |
508 |
2.66 |
- |
|
| Alexander W James |
SR. VP, Chief Medical Officer |
• – – |
2007-07-31 |
4 |
B |
$7.06 |
$16,749 |
D/D |
2,374 |
3,659 |
2.74 |
- |
|
| Mccullough David |
VP |
• – – |
2007-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Bennett J Claude |
President |
• • – |
2007-02-26 |
4 |
OE |
$1.18 |
$95,278 |
D/D |
16,171 |
65,730 |
|
- |
|
754 Records found
|
|
Page 28 of 31 |
|
|
0.24 (3.85%) 
